4//SEC Filing
SIDRANSKY DAVID 4
Accession 0000899243-22-022562
CIK 0001797336other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:15 PM ET
Size
5.4 KB
Accession
0000899243-22-022562
Insider Transaction Report
Form 4
SIDRANSKY DAVID
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+12,500→ 12,500 totalExercise: $1.63Exp: 2032-06-12→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001277161
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:15 PM ET
- Size
- 5.4 KB